TRANSDERMALES ABGABESYSTEM MIT ROTIGOTIN
European patent · EP3145502 · In force
Register entry
- Publication number
- EP3145502
- Application number
- EP15723245
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- May 20, 2015
- Published
- Mar 29, 2017
- Granted
- Jul 6, 2022
- Protection ends at the latest
- May 19, 2035
- Next annual fee due
- May 31, 2027
- IPC classes
- A61K 9/70 (2006.01)A61K 31/381 (2006.01)
- Priority
- EP 14169009 20.05.2014
- PCT application
- PCT/EP2015/061099 20.05.2015
- PCT publication
- WO2015/177204 26.11.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 1, 2026
Change
Published in Swissreg on 01.06.2026
- Jun 1, 2025
Change
Published in Swissreg on 01.06.2025
- Jun 2, 2024
Change
Published in Swissreg on 02.06.2024
- Jun 2, 2023
Change
Published in Swissreg on 02.06.2023
- May 17, 2023
Change
Published in Swissreg on 17.05.2023
- May 8, 2023
Address changed
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 08.05.2023
- Aug 2, 2022
Agent entered
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel
Published in Swissreg on 02.08.2022
- Jul 6, 2022
Granted
Published in Swissreg on 06.07.2022
Parties
Inventor
53474 Bad Neuenahr-Ahrweiler, DE
53359 Rheinbach, DE
56299 Ochtendung, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.